Cholesterol |
|
|
Clinical Trial: Effectiveness of Two Approved Drugs in Lowering High Cholesterol
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to evaluate the safety and effectiveness of two approved drugs in lowering high cholesterol when taken together, compared to taking only one of the drugs.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Hypercholesterolemia | | Phase II Phase III |
MedlinePlus related topics: Cholesterol
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: To Compare the Effectiveness of Two Approved Drugs in Lowering High Cholesterol
Eligibility
Ages Eligible for Study: 21 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Elevated cholesterol level
Exclusion Criteria:
- Liver disease
- Known allergies to study drugs
More Information
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 21, 2004
ClinicalTrials.gov Identifier: NCT00092157
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Diet Essentials- cholesterol - AOL Diet & Fitness (AOL.com)
- A Consumer's Guide to Fats (Office of Consumer Affairs, OEA, FDA,)

Not Signed In -
